These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28589621)

  • 1. Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases.
    Volkman R; Offen D
    Stem Cells; 2017 Aug; 35(8):1867-1880. PubMed ID: 28589621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment.
    Alexanian AR; Maiman DJ; Kurpad SN; Gennarelli TA
    Stem Cells Dev; 2008 Dec; 17(6):1123-30. PubMed ID: 18484898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases.
    Sadan O; Melamed E; Offen D
    Expert Opin Biol Ther; 2009 Dec; 9(12):1487-97. PubMed ID: 19821796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research.
    Frausin S; Viventi S; Verga Falzacappa L; Quattromani MJ; Leanza G; Tommasini A; Valencic E
    Acta Histochem; 2015; 117(4-5):329-38. PubMed ID: 25747736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases.
    Chen X; Wang S; Cao W
    Cell Immunol; 2018 Apr; 326():8-14. PubMed ID: 28778534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination.
    Keilhoff G; Stang F; Goihl A; Wolf G; Fansa H
    Cell Mol Neurobiol; 2006; 26(7-8):1235-52. PubMed ID: 16779672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells: potential in treatment of neurodegenerative diseases.
    Tanna T; Sachan V
    Curr Stem Cell Res Ther; 2014; 9(6):513-21. PubMed ID: 25248677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection.
    Kassis I; Vaknin-Dembinsky A; Karussis D
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):63-8. PubMed ID: 20955154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases.
    Kan I; Melamed E; Offen D
    Handb Exp Pharmacol; 2007; (180):219-42. PubMed ID: 17554511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction system of neural and muscle lineage cells from bone marrow stromal cells; a new strategy for tissue reconstruction in degenerative diseases.
    Kitada M; Dezawa M
    Histol Histopathol; 2009 May; 24(5):631-42. PubMed ID: 19283670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases.
    Lo Furno D; Mannino G; Giuffrida R
    J Cell Physiol; 2018 May; 233(5):3982-3999. PubMed ID: 28926091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.
    Karussis D; Kassis I; Kurkalli BG; Slavin S
    J Neurol Sci; 2008 Feb; 265(1-2):131-5. PubMed ID: 17610906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
    Wang J; Liao L; Tan J
    Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell transplantation for neurodegenerative diseases.
    Torrente Y; Polli E
    Cell Transplant; 2008; 17(10-11):1103-13. PubMed ID: 19181205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
    Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
    Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.
    Wyse RD; Dunbar GL; Rossignol J
    Int J Mol Sci; 2014 Jan; 15(2):1719-45. PubMed ID: 24463293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved dopamine neurotrophic factor-transduced mesenchymal stem cells promote axon regeneration and functional recovery of injured sciatic nerve.
    Liu Y; Nie L; Zhao H; Zhang W; Zhang YQ; Wang SS; Cheng L
    PLoS One; 2014; 9(10):e110993. PubMed ID: 25343619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke.
    Zhang Y; Dong N; Hong H; Qi J; Zhang S; Wang J
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells for the treatment of neurodegenerative disease.
    Joyce N; Annett G; Wirthlin L; Olson S; Bauer G; Nolta JA
    Regen Med; 2010 Nov; 5(6):933-46. PubMed ID: 21082892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases.
    Pisati F; Bossolasco P; Meregalli M; Cova L; Belicchi M; Gavina M; Marchesi C; Calzarossa C; Soligo D; Lambertenghi-Deliliers G; Bresolin N; Silani V; Torrente Y; Polli E
    Cell Transplant; 2007; 16(1):41-55. PubMed ID: 17436854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.